Se connecter S'abonner en ligne
  • Company news
  • Fund news
  • E-Mail alert service
  • Notre offre
 
ABSCIENCES [FR0010557264 / AB]

Fiche de la société


AB Science provides the summary of webcast with Key Opinion Leaders on masitinib Phase 3 results in severe asthma uncontrolled by oral corticosteroids

INFORMATION REGLEMENTEE
[02/12/2019 | 22:31]



Read all communications published by ABSCIENCES


Videos
Gestionnaires,
Emetteurs,
My favourite companies
Most read news of ABSCIENCES